NOV 2020 RR Updated CREAM.Indd
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Systems Leadership for Sustainable Development: Strategies for Achieving Systemic Change
DISCUSSION PAPER Systems Leadership for Sustainable Development: Strategies for Achieving Systemic Change Lisa Dreier, David Nabarro and Jane Nelson Systems Leadership for Sustainable Development: Strategies for Achieving Systemic Change Written by Lisa Dreier, David Nabarro and Jane Nelson Cover photos: World Economic Forum New Vision for Agriculture Initiative (upper left), Scaling Up Nutrition Movement (upper right), and Rich City Rides (below). Designed by Alison Beanland © 2019 by the CR Initiative at the Harvard Kennedy School Contents Executive Summary 4 Preface: A Tool for our Times 6 I. Systems Leadership: An emerging approach for tackling complex challenges 7 II. The Emergence of the Systems Leadership Concept 9 III. Defining Systems Leadership 13 IV. The CLEAR Framework for Leading Systems Change 17 V. The Journey of Systems Leadership: The “Aha!” Moments 28 VI. Mindsets and Behaviors of Individual Systems Leaders 35 VII. Mainstreaming Systems Leadership: The Way Forward 37 Annexes 1. Frameworks for Systems Leadership and Systems Change 39 2. CLEAR Framework Self-Assessment Questions for Systems Leadership Initiatives 43 3. List of Reviewers 45 Endnotes 46 SYSTEMS LEADERSHIP FOR SUSTAINABLE DEVELOPMENT 3 Executive Summary Addressing complex challenges through systems change The 2030 Sustainable Development Agenda includes 17 inter-related Sustainable Development Goals (SDGs), each representing complex systems – such as climate, food, health, cities – with myriad stakeholders. Achieving progress on this agenda requires a departure from traditional top-down, hierarchical and linear approaches to implementing change. Instead it requires innovative and adaptive approaches that engage broad networks of diverse stakeholders to advance progress toward a shared vision for systemic change. This approach is called Systems Leadership. -
A Menace Wrapped in a Protein: Zika and the Global Health Security Agenda
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/320677119 Title: A MENACE WRAPPED IN A PROTEIN: ZIKA AND THE GLOBAL HEALTH SECURITY AGENDA Technical Report · September 2017 DOI: 10.13140/RG.2.2.25050.85443 CITATIONS READS 2 129 5 authors, including: Helen Epstein Wilmot James Bard College Columbia University 28 PUBLICATIONS 925 CITATIONS 5 PUBLICATIONS 15 CITATIONS SEE PROFILE SEE PROFILE Ángel G Muñoz Lawrence Stanberry Columbia University Columbia University 121 PUBLICATIONS 694 CITATIONS 238 PUBLICATIONS 7,326 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: Climate informed malaria prevention, control and elimination View project ENACTS (Enhanced National Climate Services) View project All content following this page was uploaded by Ángel G Muñoz on 27 October 2017. The user has requested enhancement of the downloaded file. Title: A MENACE WRAPPED IN A PROTEIN: ZIKA AND THE GLOBAL HEALTH SECURITY AGENDA Authors: Helen Epstein, Wilmot James, Ángel G. Muñoz, Lawrence Stanberry & Madeleine C. Thomson. Reference: Columbia GHS&D Working Group Papers 2017-01 Date: September, 2017 Place: Columbia University Medical Center, Morgan Stanley Children’s Hospital, Office 102, 3959 Broadway CHC 1-102, New York City NY 10032, USA. Copyright: This work is licensed under the Creative Commons Attribution-NonCommercial- ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/. A MENACE WRAPPED IN A PROTEIN1: ZIKA AND THE GLOBAL HEALTH SECURITY AGENDA Preface Stephen Nicholas & Marc Grodman… i 1.Zika: Implications for Global Health Security Helen Epstein… 1 2.Zika Pathogenesis, Diagnosis and Vaccines Lawrence Stanberry… 12 3.Climate Change, the Environment and the Zika Outbreak Madeleine C. -
World Health Organization Gets First Leader from Africa : Nature News & Comment
NATURE | NEWS World Health Organization gets first leader from Africa Ethiopia’s Tedros Adhanom Ghebreyesus to head agency amid calls for reform. Declan Butler 23 May 2017 Fabrice Coffrini/AFP/Getty Tedros Adhanom Ghebreyesus, from Ethiopia, is the World Health Organization's next director-general. The World Health Organization (WHO) has its first director-general from Africa. Ethiopia’s Tedros Adhanom Ghebreyesus will take the top post at the agency from 1 July — succeeding Margaret Chan — after winning a 23 May vote by WHO member states at the World Health Assembly, their annual gathering in Geneva, Switzerland. Tedros is a public-health expert who has formerly been both a health minister and a foreign minister in Ethiopia’s government, and he will lead the WHO for a 5-year term. He takes the helm troubled times: the WHO’s core budget — its dues from its members — is falling, and it is now dangerously dependent on the voluntary contributions that make up the vast bulk of its spending and often come with strings attached by donors. The agency has also often been criticized for its complex, bureaucratic and ineffective management structure. Chan has spent a decade (two terms) in office. Her leadership was criticized in 2014, when the agency was slow to respond to the Ebola epidemic in West Africa. That prompted several outside reviews and ongoing reforms of ways the organization responds to disease outbreaks. Widespread horse-trading between Related stories Related stories the WHO’s member states was • Clock is ticking for WHO • Clock is ticking for WHO expected during the secret ballot for decision over Taiwan decision over Taiwan the director-general position, at which new voting rules were • The time is ripe to reform • The time is ripe to reform applied. -
The COVID-19 Infodemic* 07 08
01 Editorial 02 03 04 05 06 The COVID-19 Infodemic* 07 08 1 1 2 3 4 09 Sebastián García-Saisó, Myrna Marti, Ian Brooks, Walter H. Curioso, Diego González, 10 Victoria Malek,1 Felipe Mejía Medina,1 Carlene Radix,5 Daniel Otzoy,6 Soraya Zacarías,7 11 1 1 12 Eliane Pereira dos Santos and Marcelo D’Agostino 13 14 15 16 Suggested citation García-Saisó S, Marti M, Brooks I, Curioso WH, González D, Malek V, et al. The COVID-19 Infodemic. Rev Panam Salud Publica. 2021;45:e56. https://doi.org/10.26633/RPSP.2021.56 17 18 19 20 On 15 February 2020, during the Munich Security Conference The infodemic can negatively impact health and well-being 21 (1), the Director of the World Health Organization (WHO), Dr. and can also polarize public debate. Campaigns against public 22 Tedros Adhanom Ghebreyesus, stated that the fight against health measures, inaccurate or falsified epidemiological data, and 23 the COVID-19 pandemic was accompanied by a fight against fake or biased evidence can potentially alter people’s behavior. 24 an “infodemic”, leading to a series of initiatives by the WHO This puts extra pressure on health systems, as it undermines the 25 and other organizations to face this challenge. This situation is scope and efficiency of the various health intervention programs. 26 not new: others have occurred during other health emergen- The main factors contributing to the development of the info- 27 cies, but never one of the current magnitude, resulting from the demic are associated with a lack of digital literacy programs (5) 28 increased use of digital applications (2). -
Covid and That Other Pandemic—Lies T’S Been a Long Weekend
comment “NHS staff's TikTok dances are feeding the hostile social media beast” DAVID OLIVER “To establish trust, we need transparency and everyday language” HELEN SALISBURY PLUS Covid’s impact on defensive medicine; a child’s right not to be hit CRITICAL THINKING Matt Morgan Covid and that other pandemic—lies t’s been a long weekend. The growing number must also speak no evil. Instead, they scream it at of my colleagues self-isolating has led to the top of their lungs. Half of the profi les pushing the increasing gaps in our rota. Combined with the unethical, dangerous, and discredited case for herd unwelcome return of covid-19 to intensive care immunity through the Great Barrington Declaration Iunits throughout Europe, the long hard summer were artifi cial, bot-like accounts, amplifi ed by social is morphing into the longer, harder winter. I let out a media above the consensus view. slow exhale as I sink into my sofa after arriving home As doctors, nurses, and patients, we must move late on a Sunday night. Time to recharge, relax, and beyond blaming individuals who respond to these refl ect—but a million voices are shouting at me. bad ideas and bad incentives: instead, let us task A video on YouTube tells me that the covid tests I the companies with taking responsibility for their ordered were false. A Facebook post proclaims that output. If not, they can fund the intensive care masks are simply a tool of government oppression. beds, the staff sickness gaps, and the tissues Twitter advises me that those death certifi cates I’ve to wipe away tears when their broadcast written were lies. -
COVID-19 Speaker Key: MH Dr Margaret Harris TAG Dr Tedros
COVID-19 Speaker key: MH Dr Margaret Harris TAG Dr Tedros Adhanom Ghebreyesus TU Tu MR Dr Michael Ryan VA Vadia MK Dr Maria Van Kerkhove DI Diego IM Imogen CR Charles CO Corinne CS Costas MH Good morning, afternoon and evening. Welcome, everybody, and thank you for joining this latest WHO press briefing on COVID-19. As most of you are aware, we here at WHO headquarters in Geneva are practising physical distancing as one measure to stop COVID-19 transmission so from this week and onwards these press briefings will be held as virtual meetings with very few of us in the room. You can see we're well apart. Just some housekeeping; if you've joined online please use the raise your hand icon to indicate you want to ask a question. If you've joined by phone press # 9 on your keypad to ask a question. Listen out for your name. Sometimes names are not clear when we get them so my apologies in advance. We have here today three people who for most of you need no introduction. We have WHO director-general, Dr Tedros, our executive director of our emergency programme, Dr Mike Ryan, and our technical lead, Dr Maria Van Kerkhove. Dr Tedros will provide some opening remarks, then we'll open it for questions. I'd like to remind you we can only have one question per journalist. We've got limited time. This is a very busy time for everybody so please respect that. There are a lot of you and we want to give everybody a fair chance. -
COVID-19 Vaccination Strategy in China: a Case Study
Article COVID-19 Vaccination Strategy in China: A Case Study Marjan Mohamadi 1,†, Yuling Lin 1,*,† ,Mélissa Vuillet Soit Vulliet 1,†, Antoine Flahault 1, Liudmila Rozanova 1 and Guilhem Fabre 2 1 Institute of Global Health, University of Geneva, 1211 Geneva, Switzerland; [email protected] (M.M.); [email protected] (M.V.S.V.); antoine.fl[email protected] (A.F.); [email protected] (L.R.) 2 Department of Chinese, UFR 2, Université Paul Valéry Montpellier 3, 34199 Montpellier, France; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: The coronavirus disease 2019 (COVID-19) outbreak in China was first reported to the World Health Organization on 31 December 2019, after the first cases were officially identified around 8 December 2019. However, the case of an infected patient of 55 years old can probably be traced back on 17 November. The spreading has been rapid and heterogeneous. Economic, political and social impacts have not been long overdue. This paper, based on English, French and Chinese research in national and international databases, aims to study the COVID-19 situation in China through the management of the outbreak and the Chinese response to vaccination strategy. The coronavirus disease pandemic is under control in China through non-pharmaceutical interventions, and the mass vaccination program has been launched to further prevent the disease and progressed steadily with Citation: Mohamadi, M.; Lin, Y.; 483.34 million doses having been administered across the country by 21 May 2021. China is also Vulliet, M.V.S.; Flahault, A.; acting as an important player in the development and production of SARS-CoV-2 vaccines. -
Attendees' Briefing Pack Global Humanitarian Policy Forum 2020
ATTENDEES’ BRIEFING PACK GLOBAL HUMANITARIAN POLICY FORUM 2020 A Case for Transformation? The Longer-term Implications of the COVID-19 Pandemic Wednesday, December 9, 2020 | 9:00 am – 12:30 pm Thursday, December 10, 2020 | 9:15 am – 12:30 pm Virtual Meeting Link: https://pm1pro.zoom.us/j/92395689044 Website: https://www.unocha.org/2020-humanitarian-policy-forum 1 TABLE OF CONTENTS CONCEPT NOTE - Global Humanitarian Policy Forum 2020………………………………………….....…3 AGENDA…………………………………………………………………………………………………………………………4 CONCEPT NOTE – Beyond Health: Political, Socio-Economic and Security Dimensions of the COVID-19 Pandemic……………………………………………………………………………………..………….…...…6 CONCEPT NOTE – Coalitions for Success: New Partnerships and Local Frontline Leadership………………………………………………...…………………………………………………………....…....10 CONCEPT NOTE – Future Proofing: Organizational Readiness & Strategic Crisis Preparedness……….................................................................................................................................................13 CONCEPT NOTE – Realizing the Digital Promise: Moving New and Emerging Technologies from Pilots to Practice……....................................................................................................................................16 2 CONCEPT NOTE – GLOBAL HUMANITARIAN POLICY FORUM A Case for Transformation? The Longer-term Implications of the COVID-19 Pandemic Wednesday, December 9, 2020 9:00 am – 12:30 pm Thursday, December 10, 2020, 9:15 am – 12:30 pm Virtual Meeting Link: https://pm1pro.zoom.us/j/92395689044 -
The Covid–19 Pandemic and Haemoglobin Disorders
THE COVID–19 PANDEMIC AND HAEMOGLOBIN DISORDERS VACCINATIONS & THERAPEUTIC DRUGS An Informational Guide from the Thalassaemia International Federation (TIF) Prepared by: Dr Androulla Eleftheriou, Executive Director, TIF Last Updated: 12 May 2020 VACCINATIONS & THERAPEUTIC DRUGS Introduction It is important to note that there are currently no FDA1 or EMA2-approved or even recommended agents for the treatment of the novel coronavirus (COVID-19), for which the World Health Organization (WHO) declared as pandemic on Wednesday 11th of March 2020. Any agent being used at this time is being administered in an experimental setting under controlled conditions. Thalassaemia International Federation (TIF) has made an effort to compile a list of studies/clinical trials for treatment and vaccines, which is by no means exhaustive as this situation is extremely labile and research in this area is dramatically intensified. New information is anticipated to be added to this guide which is prepared exclusively for TIF’s global thalassemia community. The viral genome was mapped very soon as rom early January 2020 and shared globally. In February 2020, the WHO published an overview of the potential therapeutic candidates for the treatment of COVID-19. The document outlines 76 regimens that have been proposed (as of February 17, 2020) for the treatment of patients infected with the virus. Thirty-eight of these candidates are in the preclinical state with minimal information available on their proposed mechanism, uses, doses routes, or planned trials. Sixteen of the remaining regimens contain an interferon-based product. The rest include a variety of antimicrobials, corticosteroids, convalescent plasma, and biologics. The Director-General of the WHO, Mr Tedros Adhanom, stated on the 10th of April 2020, that more than 70 countries have joined WHO’s trial to accelerate research on effective treatments and 20 Institutions and companies ‘are racing to develop a vaccine’. -
Security Council Provisional Asdf Sixty-Ninth Year 7268Th Meeting Thursday, 18 September 2014, 2.45 P.M
United Nations S/ PV.7268 Security Council Provisional asdf Sixty-ninth year 7268th meeting Thursday, 18 September 2014, 2.45 p.m. New York President: Ms. Power/Mr. Dunn . ............................. (United States of America) Members: Argentina ...................................... Mrs. Perceval Australia . Mr. Quinlan Chad .......................................... Mr. Mangaral Chile .......................................... Mr. Barros Melet China ......................................... Mr. Wang Min France ......................................... Mr. Delattre Jordan ......................................... Mrs. Kawar Lithuania ....................................... Ms. Murmokaitė Luxembourg .................................... Ms. Lucas Nigeria . ........................................ Mr. Sarki Republic of Korea ................................ Mr. Oh Joon Russian Federation ............................... Mr. Maksimychev Rwanda ........................................ Mr. Nduhungirehe United Kingdom of Great Britain and Northern Ireland ... Sir Mark Lyall Grant Agenda Peace and security in Africa Ebola This record contains the text of speeches delivered in English and of the translation of speeches delivered in other languages. The final text will be printed in the Official Records of the Security Council. Corrections should be submitted to the original languages only. They should be incorporated in a copy of the record and sent under the signature of a member of the delegation concerned to the Chief of the Verbatim Reporting -
Icn at the 73Rd World Health Assembly, 2020 and the 148Th Who Executive Board, 2021
INTERNATIONAL COUNCIL OF NURSES ICN AT THE 73RD WORLD HEALTH ASSEMBLY, 2020 AND THE 148TH WHO EXECUTIVE BOARD, 2021 Prepared by Erica Burton - ICN Senior Advisor, Nursing & Health Policy TABLE OF CONTENTS INTRODUCTION .............................................................................................................3 OPENING OF THE RESUMED WHA73 ........................................................................3 Address by WHO Director-General Dr Tedros Adhanom Ghebreyesus WHA73 3 Keynote address by Her Royal Highness Princess Muna Al-Hussein of Jordan (HRH), WHO Patron for Nursing & Midwifery .........................................................4 OPENING OF THE EB148 ..............................................................................................5 Address by WHO Director-General Dr Tedros Adhanom Ghebreyesus .............5 COVID-19 response ..................................................................................................5 WHO’s work in health emergencies .......................................................................6 Strengthening WHO’s global emergency preparedness and response .......6 .....Strengthening preparedness for health emergencies: implementation of the International Health Regulations (2005) .................................................................7 Interim progress report of the Review Committee on the functioning of the International Health Regulations (2005) during the COVID-19 response ............7 Mental health preparedness and response for the COVID-19 -
Brazil Notches New Daily COVID Death Record 10 March 2021
Brazil notches new daily COVID death record 10 March 2021 "The fight against COVID-19 was lost in 2020 and there is not the slightest chance of reversing this tragic circumstance in the first half of 2021," epidemiologist Jesem Orellana of Fiocruz/Amazonia told AFP. "The best we can do is hope for the miracle of mass vaccination or a radical change in the management of the pandemic," he said. "Today, Brazil is a threat to humanity and an open- air laboratory where impunity in management seems to be the rule." President Jair Bolsonaro, who flouts expert advice Credit: Pixabay/CC0 Public Domain on fighting the coronavirus, last week urged Brazilians to "stop whining" about COVID-19 and renewed his attacks on stay-at-home measures. Brazil broke its record for new daily COVID-19 Tedros Adhanom Ghebreyesus, the director deaths on Tuesday with nearly 2,000 fatalities, as general of the World Health Organization, has the pandemic overwhelms hospitals and urged the country to take aggressive steps, warning vaccinations progress slowly. that Brazil could affect its neighbors and beyond if it didn't take the virus seriously. The Health Ministry reported a daily total of 1,972 new deaths in the country, which has the world's Brazil's vaccine campaign is progressing slowly. A second-highest overall toll, exceeded only by the total of 8.6 million people (4.1 percent of the United States. population) have received a first dose of vaccine, and only 2.9 million have received a second dose. It also reported 70,764 new cases of COVID-19, meaning 11.1 million people have now caught the The vaccines under use in Brazil are CoronaVac, virus in the country, while a total of 268,370 have which was developed by Chinese firm Sinovac, and died.